Pacific Biosciences of California Inc PACB

NAS: PACB | ISIN: US69404D1081 15:48

1,990 USD (-1,49%)

(-1,49%) 15:48

Grafiek Pacific Biosciences of California Inc

Grafiek Pacific Biosciences of California Inc

1 dag1d -1,49%
1 week1w 3,11%
1 maand1m 27,56%
3 maanden3m -62,38%
6 maanden6m -76,81%
1 jaar1j -84,76%
5 jaar5j -71,93%

Pacific Biosciences of California Inc in het nieuws

Toon enkel gratis nieuws

15 mei 2024 · Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases · Persbericht

9 mei 2024 · PacBio Announces First Quarter 2024 Financial Results · Persbericht

16 april 2024 · PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance · Persbericht

27 maart 2024 · Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes · Persbericht

22 maart 2024 · PacBio Grants Equity Incentive Award to New Employee · Persbericht

12 maart 2024 · PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions · Persbericht

26 februari 2024 · PacBio to Present at Upcoming Investor Conferences · Persbericht

15 februari 2024 · PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results · Persbericht

13 februari 2024 · Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch · Persbericht

5 februari 2024 · PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale · Persbericht

Profiel Pacific Biosciences of California Inc

Gezondheidstechnologie

Productie van analytische laboratoriuminstrumenten

Werknemers: 699

Aandelen Pacific Biosciences of California Inc

Beurswaarde: 550,16 miljoen USD

Effecten: 272,36 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 2,56

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe